Pharma Journalist -

Sanofi and Regeneron Pharmaceuticals, Inc. announced positive results from two Phase 3b/4 ODYSSEY-DM trials in patients with diabetes. In the studies, Praluent® (alirocumab), when…
Read More...

Eurofins Scientific announces the acquisition of Alphora Research Inc., a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small…
Read More...

Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a…
Read More...

Selexis SA and TeneoBio announced that they have entered into a service agreement to advance the development of a new class of biologics, Human Heavy-Chain Antibodies (UniAbs) targeting…
Read More...

Midatech Pharma announced that it has signed a global licensing agreement with Novartis for the oncology compound panobinostat. Panobinostat will be developed by Midatech for the…
Read More...

Australian researchers have found a new way to use immunotherapy, a breakthrough mode of cancer treatment which harnesses the patient’s immune system, to treat an aggressive form of…
Read More...

Kleo Pharmaceuticals announced the appointment of Douglas J. Manion, M.D. FRCP(C) as Chief Executive Officer, effective immediately. Dr. David Spiegel M.D., Ph.D., co-founder of Kleo,…
Read More...

Olon S.p.A. announced the acquisition of Ricerca Biosciences' Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the…
Read More...

Tekni-Plex, Inc. is announcing a $15 million investment in a new state-of-the-art manufacturing facility in Suzhou, China, near Shanghai. It represents the single largest recent…
Read More...

Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc, an…
Read More...